Abstract
Shortly after the discovery of the Epstein-Barr virus (EBV) in cultured Burkitt’s lymphoma (BL) cells, the association of the virus with another human malignant disease became apparent. Old et al. [21] noted first that patients with nasopharyngeal carcinoma (NPC) have unusually high antibody titers against viral antigens. This finding has since been widely confirmed and extended (for review, see [7, 10]). NPC is characterized by particular epidemiological features. It is the most frequent cancer in adult males in some parts of south China, with an age peak between 45 and 55 years. It occurs, however, with a lesser frequency all over the world. The Mediterranean countries are known as areas with an intermediate risk. Remarkably, there is a second peak at the age of 10–20 years for the occurrence of NPC outside China.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersson-Anvret M, Forsby N, Klein G, Henle W: Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int. J. Cancer 20 (1977) 486–494
Bayliss GJ, Wolf H: An Epstein-Barr virus early protein induces cell fusion. Proc. Natl. Acad. Sei. USA 78 (1981) 7162–7165
Bornkamm GW, Delius H, Zimber U, Hudewentz J, Epstein MA: Comparison of Epstein-Barr virus strains of different origin by analysis of viral DNAs. J. Virol. 35 (1980) 603–618
Brichacek B, Hirsch I, Sibl O, Vilikusova E, Vonka V: Association of some supraglottic laryngeal carcinomas with EB virus. Int. J. Cancer 32 (1983) 193–197
Brichacek B, Hirsch I, Sibl O, Vilikusova E, Vonka V: Presence of Epstein-Barr virus DNA in carcinoma of the palatine tonsil. J. Natl. Cancer Inst. 72 (1984) 809 - 811
Crawford DH, Epstein MA, Bornkamm GW, Achong BG, Finerty S, Thompson JL: Bio-logical and biochemical properties of isolates of Epstein-Barr virus from the malignant epithelial cells of two nasopharyngeal carcinomas. Int. J. Cancer 24 (1979) 294–302
Epstein MA, Achong BG (eds): The Epstein-Barr virus. Springer Verlag, Berlin-Heidelberg-New York 1979
Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, Freese UK: Replication of Epstein-Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313 (1985) 1564–1571
Henle G, Henle W: Epstein-Barr virus-specific Ig A serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17 (1976) 1–17
Henle W, Henle G: Epstein-Barr virus and human malignancies. In: Advances in Viral Oncology, Vol.5, Klein G (ed), Raven Press, New York (1985) 201–238
Henle W, Ho JHC, Henle G, Chan JCW, Kwan HC: Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Int. J. Cancer 20 (1977) 663–672
Ho JHC, Kwan HC, Ng MN, de Thé G: Serum IgA antibodies to Epstein-Barr virus capsid antigen preceding symptoms of nasopharyngeal carcinoma cells. Lancet 1 (1978) 436
Huang DP, Ho JHC, Henle W, Henle G: Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int. J. Cancer 14 (1974) 580–588
Kaschka-Dierich C, Adams A, Lindahl T, Bornkamm GW, Bjursell G, Klein G: Intracel¬lular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature 260 (1976) 302–306
Krueger GRF, Wustrow J: Current histological classification of nasopharyngeal carcinoma (NPC) at Cologne University. In: Cancer Campaign, Vol. 5, Nasopharyngeal Carcinoma, Grundmann E, Krueger GRF, Ablashi DV (eds), Gustav Fischer Verlag, Stuttgart-New York (1981) pp. 11–16
Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, Dohan PH: Association of Epstein-Barr virus with nasopharyngeal carcinoma in Alaskan native patients: serum antibodies and tissue EBNA and DNA. Int. J. Cancer 28 (1981) 301–305
Laux G, Freese UK, Bornkamm GW: Structure and evolution of two related transcription units of Epstein-Barr virus carrying small tandem repeats. J. Virol. 56 (1985) 987–995
Leyvraz S, Henle W, Chaninian AP, Perlmann C, Klein G, Gordon RE, Rosenblum M, Holland JF: Association of Epstein-Barr virus with thymic carcinoma. New Engl. J. Med. 312 (1985) 1296–1299
Misko IS, Moss DJ, Pope JH: HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 77 (1980) 4247–4250
Morgan DG, Miller G, Niederman JC, Smith HW, Dowaliby JM: Site of Epstein-Barr virus replication in the oropharynx. Lancet II (1979) 1154–1157
Old LJ, Boyse EA, Oettgen HF, de Herven E, Geering G, Williams B, Clifford P: Precipitating antibody in human serums to an antigen present in cultured Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. USA 56 (1966) 1691–1704.
Raab-Traub N, Hood R, Yang C-S, Henry II B, Pagano JS: Epstein-Barr virus transcription in nasopharyngeal carcinoma. J. Virol. 48 (1983) 580–590
Reedman B, Klein G: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11 (1973) 499–520
Rickinson AB, Wallace LE, Epstein MA: HLA-restricted T cell recognition of Epstein-Barr virus infected B cells. Nature 283 (1980) 865–867
Semundsen AK, Albeck H, Hansen JPH: Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas in Greenland Eskimoes. Br. J. Cancer 46 (1982) 721–728
Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS: Epstein-Barr virus replication in oropharyngeal epithelial cells. New Engl. J. Med. 310 (1984) 1225–1230
Strauch B, Andrews LL, Siegel N, Miller G: Oropharyngeal excretion of Epstein-Barr virus by renal transplant patients and other patients treated with immunosuppressive drugs. Lancet I (1974) 234–237
Svedmyr E, Jondal M: Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectous mononucleosis. Proc. Natl. Acad. Sci. USA 72 (1975) 1622–1626
Wolf H, zur Hausen H, Becker V: EB-viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol. 244 (1973) 245–247
Wolf H, Haus M, Wilmes E: Persistence of Epstein-Barr virus in the parotid gland. J. Virol. 51 (1984) 795–798
Yao QY, Rickinson AB, Gaston JSH, Epstein MA: In vitro analysis of the Epstein-Barr virus — host balance in longterm renal allograft recipients. Int. J. Cancer 35 (1985) 43–49
Zeng Y, Yuxi L, Chunren L, Sanwen C, Jihneng W, Jisong Z, Huijong Z: Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma. Intervirology 13 (1980) 162–168
zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L: EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228 (1970) 1056–1058
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag
About this chapter
Cite this chapter
Bornkamm, G.W. (1987). The Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma. In: Wagner, G., You-Hui, Z. (eds) Cancer of the Liver, Esophagus, and Nasopharynx. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71510-5_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-71510-5_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16967-3
Online ISBN: 978-3-642-71510-5
eBook Packages: Springer Book Archive